Please enable JavaScript.
Coggle requires JavaScript to display documents.
DRUGS FOR D.M - Coggle Diagram
DRUGS FOR D.M
Effectiveness on HbA1c
High
SU (1-1.5%)
TZD (0.5-1.4%)
GLP-1 RAs (0.6-1.5%)
Metformin (1-1.5%)
Mediate
SGLT-2i (0.5-1%)
DPP-4 (0.5-1%)
Alpha-glucosidase (0.5-0.8%)
Highest
Insulin
Risk of hypoglycemia
Insulin
SU
Weight change
Weight loss
SGLT-2i
GLP-1 RA
Weight gain
Insulin
TZD
SU
Affect on cardiovascular system
CHF
benefit with evidence
SGLT-2i
Potential risk
DPP-4i
alogliptin
saxaliptine
Increasing risk
TZD
ASCVD
Potential benefit
Metformin
TZD
Pioglitazone
Benefit with evidene
SGLT-2i (except: lixisenatide)
Canagliflozine
Empagliflozine
GLP-1 RAs
Semaglutide
Exenatide
Liraglutide
Cost
Cheap
TZD
Human Insuline
Metformin
SU
Expensive
DPP-4i
GLP-1 RA
SGLT2-i
Insuline analog